Natural history of perinatal hepatitis C virus infection

Clinical Infectious Diseases

Volumn 23, Issue 1, 1996, Pages 47-50

  Palomba, Elvia ^a   Manzini, Paola ^a   Fiammengo, Paolo ^a   Maderni, Paola ^a   Saracco, Giorgio ^a   Tovo, Pier Angelo ^a  

^a Department of Pediatrics ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; ARTICLE; DISEASE ACTIVITY; EARLY DIAGNOSIS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HISTORY; HUMAN; HUMAN CELL; INFECTION RISK; INFLAMMATORY CELL; PERINATAL PERIOD; PRIORITY JOURNAL; VIREMIA; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0029809774     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.1.47     Document Type: Article

References (19)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
2. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.
3. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II [letter]. J Infect Dis 1990;162:569-70.
4. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-3.
5. Colombo M, Kuo G, Choo QL, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;2:1006-8.
6. Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;2:1004-6.
7. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. N Engl J Med 1989;321:1501-6.
8. Thaler MM, Park C-K, Landers DV, et al. Vertical transmission of hepatitis C virus. Lancet 1991;338:17-8.
9. Lam JPH, McOmish F, Burns SM, Yap PL, Mok JYQ, Simmonds P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis 1993;167:572-6.
10. Ohto H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994;330:744-50.
11. Manzini P, Saracco G, Cerchier A, et al. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology 1995;21:328-32.
12. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995;345:289-91.
13. Paccagnini S, Principi N, Massironi E, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995;14:195-9.
14. Tovo P-A, Riva C, Palomba E, et al. Herpesvirus infections do not influence the course of perinatal HIV-1 infection. Pediatr AIDS HIV Infect Fetus Adolesc 1994;5:180-3.
15. Farci P, Alter HJ, Wong D, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991;325:98-104.
16. Fung J, Köhler H. Mechanism of neonatal idiotype suppression. II. Alterations in the T cell compartment suppress the maturation of B cell precursors. J Immunol 1980;125:2489-95.
17. Hellström UB, Sylvan SPE, Decker RH, Sönnerborg A. Immunoglobulin M reactivity towards the immunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection. J Med Virol 1993;39:325-32.
18. Quiroga JA, Bosch O, Gonzalez R, et al. Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C. Gastroenterology 1992;103:1285-9.
19. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993;88:240-3.